SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Fink who wrote (331)10/18/1997 5:33:00 PM
From: Vector1   of 1754
 
James, i usually don't post on this thread but your post was so moronic I felt compelled. VISX will make it or not in the long run based on the number of proceedures for which they get royalties. To use the often business school cited example of Gillette the machines are the razors and the proceedure royalty are the blades. The key indicator is the growth in proceedures which pay royalties which is showing strong consistent growth. IMHO this will continue as black boxes are taken out of the system and the major laser centers which use VISX machines expand. If I have one criticsm of VISX it is that they should be selling the machines at even lower prices with better terms in order to increase the growth in proceedures. Obviously this would benefit BEAM as well.
V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News